Melanoma Trial, Recruiting (NCT00001823)

Melanoma Trial, Recruiting NCT00001823 Sponsor: National Cancer Institute (NCI) Condition: Melanoma

Printed from Voxsanity (voxsanity.com.au) — NCT00001823 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Melanoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years old or older.
You have either been diagnosed with cancer (confirmed by a tissue sample/biopsy) or doctors suspect you may have cancer.
You are able to understand the study information and are willing to sign a consent form agreeing to take part.
You are already being considered for treatment under an NCI Surgery Branch research study.

Who may not be able to join:

Women who are pregnant or planning to become pregnant may not be able to join, because some of the screening tests used in this study (such as nuclear medicine scans or other imaging) could potentially be harmful to an unborn baby.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Steven A Rosenberg, M.D., National Cancer Institute (NCI)

Phone: (866) 820-4505

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT00001823

Sponsor: National Cancer Institute (NCI)

Phase: Not Applicable

Status: Recruiting

Condition: Melanoma

Trial contact: (866) 820-4505

More information: https://clinicaltrials.gov/study/NCT00001823

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years old or older.
You have either been diagnosed with cancer (confirmed by a tissue sample/biopsy) or doctors suspect you may have cancer.
You are able to understand the study information and are willing to sign a consent form agreeing to take part.
You are already being considered for treatment under an NCI Surgery Branch research study.

Who may not be able to join:

Women who are pregnant or planning to become pregnant may not be able to join, because some of the screening tests used in this study (such as nuclear medicine scans or other imaging) could potentially be harmful to an unborn baby.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Cancer Institute (NCI)

Registry

ClinicalTrials.gov

Start date

11 July 1999

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of individuals suitable for NCI Surgery Branch clinical research protocols; Frequency of HLA type, gene specific mutations, or expression of neoantigens in malignant tumors; Results of screening tests

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov